Loading clinical trials...
Loading clinical trials...
A Single-blind, Placebo-controlled, Two Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of GSK2018682 in Healthy Volunteers
Conditions
Interventions
GSK2018682
Placebo
Locations
2
Australia
GSK Investigational Site
Randwick, New South Wales, Australia
GSK Investigational Site
Adelaide, South Australia, Australia
Start Date
May 21, 2010
Primary Completion Date
December 20, 2010
Completion Date
December 20, 2010
Last Updated
June 9, 2017
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions